Keeping Track: Veklury NDA Arrives At US FDA; Olinvyk Sees Approval; MAb Filings By Regneron, Y-mAbs

The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.

Keeping Track Feature image
Novel Opioid agonist Olinvyk Restricted To ‘Controlled Clinical Settings’

Recent days have made clear some upcoming milestones in two of the most vexing therapeutic areas: COVID-19 and Alzheimer’s disease.

The race to develop a treatment for COVID-19 saw the first submission of a new drug application for US Food...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from US FDA Performance Tracker

More from Regulatory Trackers